[{"id":"69c63340-f0e4-4849-b2f7-9e47c121183d","acronym":"","url":"https://clinicaltrials.gov/study/NCT00458536","created_at":"2021-01-18T01:37:33.508Z","updated_at":"2024-07-02T16:35:11.645Z","phase":"Phase 1/2","brief_title":"Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF","source_id_and_acronym":"NCT00458536","lead_sponsor":"Beth Israel Deaconess Medical Center","biomarkers":" CSF2","pipe":"","alterations":" ","tags":["CSF2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Dendritic cell renal cell carcinoma fusion vaccine"],"overall_status":"Completed","enrollment":" Enrollment 38","initiation":"Initiation: 10/01/2004","start_date":" 10/01/2004","primary_txt":" Primary completion: 12/01/2014","primary_completion_date":" 12/01/2014","study_txt":" Completion: 07/01/2023","study_completion_date":" 07/01/2023","last_update_posted":"2024-04-03"}]